Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer

Author: Wissing Michel D   van Diest Paul J   van der Wall Elsken   Gelderblom Hans  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.22, Iss.5, 2013-06, pp. : 635-661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract